Avantor (AVTR): are the analysts right?

Avantor · Health Care · ref. ETF XLV · 87 calls · price $9.91
What the company does: Avantor fournit des produits et services critiques aux secteurs de la biopharmacie, santé, technologie avancée et matériaux appliqués.
📈 1-year price
$10.2-25.8% over range
Jul 8, 25low $7.41 · high $15.6Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
20% recommend buying · 5 analysts
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.

🎯 Analyst price target on AVTR

High target · 1 analyst$14+41.3%
Median target · 5 analysts$9-9.2%
Low target · 2 analysts$8-19.3%
Current price$9.91

🗳️ The analyst consensus

Analyst breakdown · 5 (6 months)
Strong Buy0%
Buy20%
Hold60%
Sell20%
Strong Sell0%

✅ Historical analyst reliability on AVTR

Most reliable analysts on AVTR (% profitable · 365j · ≥2 calls)
Raymond James 42% -9.7% 12
Baird 33% -15.5% 12
Evercore ISI Group 33% -17.8% 9
Barclays 25% -24.9% 12
RBC Capital 0% -42.9% 2
Wells Fargo 0% -46.4% 3

📊 What $1,000 invested in Avantor would be worth

In short — $1,000 invested in Avantor 10 years ago would be worth $683 today, i.e. -5%/yr on average. Best year: 2020 (+53%), worst: 2022 (-50%). Price performance, excluding dividends.

If I'd invested $1,000 in Avantor

InvestmentWorth todayGain
1 years ago$455-55%
3 years ago$469-53%
5 years ago$352-65%
since inception (2019)$683-32%

Return by year (Avantor)

YearReturn$1,000 invested at year start
2026 (YTD)-14%$864 (-14%)
2025-47%$455 (-55%)
2024-5%$434 (-57%)
2023+8%$469 (-53%)
2022-50%$235 (-77%)
2021+50%$352 (-65%)
2020+53%$538 (-46%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on AVTR

Barclays
Jun 24, 26
▼ Underweight · 🎯$8
Price at call : $10.08 — upside -21%
Today : $9.91 — upside -19%
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Jun 24, 27
Citigroup
Apr 30, 26
■ Neutral neutral · not a buy · 🎯$9
Price at call : $7.96 — gap to target +13%
Today : $9.91 — gap to target -9%
🎯 on AVTR : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Apr 30, 27
■ In-Line neutral · not a buy · 🎯$8
Price at call : $7.96 — gap to target +1%
Today : $9.91 — gap to target -19%
🎯 on AVTR : 33% (9 calls matureds) · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Apr 30, 27
Barclays
Apr 15, 26
▼ Underweight · 🎯$7
Price at call : $8.26 — upside -15%
Today : $9.91 — upside -29%
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Apr 15, 27
■ In-Line neutral · not a buy · 🎯$8.5
Price at call : $8 — gap to target +6%
Today : $9.91 — gap to target -14%
🎯 on AVTR : 33% (9 calls matureds) · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Apr 6, 27
Barclays
Mar 6, 26
▼ Underweight · 🎯$8.5
Price at call : $8.17 — upside +4%
Today : $9.91 — upside -14%
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Mar 6, 27
Wells Fargo
Feb 13, 26
▲ Overweight · 🎯$14
Price at call : $9.05 — upside +55%
Today : $9.91 — upside +41%
🎯 on AVTR : 0% (3 calls matureds) · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Feb 13, 27
Citigroup
Feb 12, 26
■ Neutral neutral · not a buy · 🎯$11
Price at call : $9.2 — gap to target +20%
Today : $9.91 — gap to target +11%
🎯 on AVTR : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Feb 12, 27
Barclays
Feb 12, 26
■ Equal-Weight neutral · not a buy · 🎯$9
Price at call : $9.2 — gap to target -2%
Today : $9.91 — gap to target -9%
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Feb 12, 27
TD Cowen
Jan 7, 26
■ Hold neutral · not a buy · 🎯$12
Price at call : $12.06 — gap to target -0%
Today : $9.91 — gap to target +21%
🎯 on AVTR : no call matured yet · 📊 on Health : 61.9% · +26.8% (21 calls)
in progress (365j)
matures : Jan 7, 27
■ In-Line neutral · not a buy · 🎯$12
Price at call : $12.27 — gap to target -2%
Today : $9.91 — gap to target +21%
🎯 on AVTR : 33% (9 calls matureds) · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Jan 5, 27
Jefferies
Dec 17, 25
▼ Underperform · 🎯$9
Price at call : $11.1 — upside -19%
Today : $9.91 — upside -9%
🎯 on AVTR : no call matured yet · 📊 on Health : 48% · +9.7% (98 calls)
in progress (365j)
matures : Dec 17, 26
▲ Outperform · 🎯$14
Price at call : $11.82 — upside +18%
Today : $9.91 — upside +41%
🎯 on AVTR : 33% (9 calls matureds) · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Oct 30, 26
Barclays
Oct 30, 25
■ Equal-Weight neutral · not a buy · 🎯$12
Price at call : $11.05 — gap to target +9%
Today : $9.91 — gap to target +21%
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Oct 30, 26
JP Morgan
Oct 30, 25
■ Neutral neutral · not a buy · 🎯$12
Price at call : $11.05 — gap to target +9%
Today : $9.91 — gap to target +21%
🎯 on AVTR : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Oct 30, 26
Baird
Oct 24, 25
▲ Outperform · 🎯$17
Price at call : $15.4 — upside +10%
Today : $9.91 — upside +72%
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : Oct 24, 26
Raymond James
Oct 16, 25
▲ Outperform · 🎯$16
Price at call : $14.78 — upside +8%
Today : $9.91 — upside +61%
🎯 on AVTR : 42% (12 calls matureds) · 📊 on Health : 42.2% · -4.2% (109 calls)
in progress (365j)
matures : Oct 16, 26
Barclays
Oct 2, 25
▲ Overweight · 🎯$15
Price at call : $14.29 — upside +5%
Today : $9.91 — upside +51%
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Oct 2, 26
Stifel
Aug 4, 25
■ Hold neutral · not a buy · 🎯$12
Price at call : $11.64 — gap to target +3%
Today : $9.91 — gap to target +21%
🎯 on AVTR : 0% (1 call matured) · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Aug 4, 26
JP Morgan
Aug 4, 25
▲ Overweight · 🎯$14
Price at call : $11.64 — upside +20%
Today : $9.91 — upside +41%
🎯 on AVTR : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Aug 4, 26
▲ Outperform · 🎯$16
Price at call : $11.64 — upside +37%
Today : $9.91 — upside +61%
🎯 on AVTR : 33% (9 calls matureds) · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Aug 4, 26
■ Equal-Weight neutral · not a buy · 🎯$12
Price at call : $11.64 — gap to target +3%
Today : $9.91 — gap to target +21%
🎯 on AVTR : 0% (1 call matured) · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Aug 4, 26
Barclays
Aug 4, 25
▲ Overweight · 🎯$13
Price at call : $11.64 — upside +12%
Today : $9.91 — upside +31%
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Aug 4, 26
Wells Fargo
Aug 4, 25
▲ Overweight · 🎯$16
Price at call : $11.64 — upside +37%
Today : $9.91 — upside +61%
🎯 on AVTR : 0% (3 calls matureds) · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Aug 4, 26
RBC Capital
Aug 4, 25
▲ Outperform · 🎯$17
Price at call : $11.64 — upside +46%
Today : $9.91 — upside +72%
🎯 on AVTR : 0% (2 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Aug 4, 26
▲ Outperform · 🎯$14
Price at call : $11.3 — upside +24%
Today : $9.91 — upside +41%
🎯 on AVTR : 42% (12 calls matureds) · 📊 on Health : 42.2% · -4.2% (109 calls)
in progress (365j)
matures : Aug 4, 26
Baird
Aug 4, 25
▲ Outperform · 🎯$15
Price at call : $11.3 — upside +33%
Today : $9.91 — upside +51%
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : Aug 4, 26
Baird
Jul 28, 25
▲ Outperform · 🎯$18
Price at call : $13.99 — upside +29%
Today : $9.91 — upside +82%
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : Jul 28, 26
Goldman Sachs
Apr 29, 25
■ Neutral neutral · not a buy · 🎯$14
Price at call : $12.69 — gap to target +10%
Today : $9.91 — gap to target +41%
🎯 on AVTR : no call matured yet · 📊 on Health : 52.2% · +7.8% (90 calls)
in progress (365j)
matures : Apr 29, 26
RBC Capital
Apr 28, 25
▲ Outperform · 🎯$20
Price at call : $12.69 — upside +58%
Today : $9.91 — upside +102%
Expected +58% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 0% (2 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-38.1%
stock -38% · XLV +3%
Stifel
Apr 28, 25
■ Hold neutral · not a buy · 🎯$14
Price at call : $12.69 — gap to target +10%
Today : $9.91 — gap to target +41%
🎯 on AVTR : 0% (1 call matured) · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Apr 28, 26
Barclays
Apr 28, 25
▲ Overweight · 🎯$15
Price at call : $12.49 — upside +20%
Today : $9.91 — upside +51%
Expected +20% · Actual -37% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-37.1%
stock -37% · XLV +4%
■ Equal-Weight neutral · not a buy · 🎯$15
Price at call : $12.49 — gap to target +20%
Today : $9.91 — gap to target +51%
🎯 on AVTR : 0% (1 call matured) · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Apr 28, 26
Baird
Apr 28, 25
▲ Outperform · 🎯$17
Price at call : $12.49 — upside +36%
Today : $9.91 — upside +72%
Expected +36% · Actual -37% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
-37.1%
stock -37% · XLV +4%
Wells Fargo
Apr 17, 25
▲ Overweight · 🎯$22
Price at call : $14.96 — upside +47%
Today : $9.91 — upside +122%
Expected +47% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 0% (3 calls matureds) · 📊 on Health : 46% · +2.8% (126 calls)
-43.2%
stock -43% · XLV +11%
Barclays
Apr 10, 25
▲ Overweight · 🎯$18
Price at call : $15.22 — upside +18%
Today : $9.91 — upside +82%
Expected +18% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-46.3%
stock -46% · XLV +8%
Citigroup
Mar 4, 25
■ Neutral neutral · not a buy · 🎯$18
Price at call : $15.75 — gap to target +14%
Today : $9.91 — gap to target +82%
🎯 on AVTR : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Mar 4, 26
▲ Overweight · 🎯$25
Price at call : $18.39 — upside +36%
Today : $9.91 — upside +152%
Expected +36% · Actual -48% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 0% (1 call matured) · 📊 on Health : 33.3% · -9.0% (159 calls)
-47.6%
stock -48% · XLV +7%
Raymond James
Feb 10, 25
▲ Outperform · 🎯$24
Price at call : $18.39 — upside +31%
Today : $9.91 — upside +142%
Expected +31% · Actual -48% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 42% (12 calls matureds) · 📊 on Health : 42.2% · -4.2% (109 calls)
-47.6%
stock -48% · XLV +7%
RBC Capital
Feb 10, 25
▲ Outperform · 🎯$31
Price at call : $18.39 — upside +69%
Today : $9.91 — upside +213%
Expected +69% · Actual -48% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 0% (2 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-47.6%
stock -48% · XLV +7%
Wells Fargo
Feb 10, 25
▲ Overweight · 🎯$25
Price at call : $18.39 — upside +36%
Today : $9.91 — upside +152%
Expected +36% · Actual -48% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 0% (3 calls matureds) · 📊 on Health : 46% · +2.8% (126 calls)
-47.6%
stock -48% · XLV +7%
Barclays
Feb 10, 25
▲ Overweight · 🎯$23
Price at call : $19.01 — upside +21%
Today : $9.91 — upside +132%
Expected +21% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-41.3%
stock -41% · XLV +6%
Stifel
Feb 10, 25
▲ Buy · 🎯$26
Price at call : $19.01 — upside +37%
Today : $9.91 — upside +162%
Expected +37% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 0% (1 call matured) · 📊 on Health : 47.2% · +12.4% (89 calls)
-41.3%
stock -41% · XLV +6%
Barclays
Feb 3, 25
▲ Overweight · 🎯$26
Price at call : $22.01 — upside +18%
Today : $9.91 — upside +162%
Expected +18% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-49.4%
stock -49% · XLV +6%
Raymond James
Jan 21, 25
▲ Outperform · 🎯$26
Price at call : $22.1 — upside +18%
Today : $9.91 — upside +162%
Expected +18% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 42% (12 calls matureds) · 📊 on Health : 42.2% · -4.2% (109 calls)
-44.6%
stock -45% · XLV +11%
UBS
Jan 17, 25
■ Neutral neutral · not a buy · 🎯$25
Price at call : $22.11 — gap to target +13%
Today : $9.91 — gap to target +152%
🎯 on AVTR : 0% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Jan 17, 26
Wells Fargo
Oct 28, 24
▲ Overweight · 🎯$28
Price at call : $22.52 — upside +24%
Today : $9.91 — upside +183%
Expected +24% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 0% (3 calls matureds) · 📊 on Health : 46% · +2.8% (126 calls)
-48.6%
stock -49% · XLV -3%
Baird
Oct 28, 24
▲ Outperform · 🎯$26
Price at call : $22.64 — upside +15%
Today : $9.91 — upside +162%
Expected +15% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
-33.4%
stock -33% · XLV -2%
Barclays
Oct 25, 24
▲ Overweight · 🎯$25
Price at call : $22.64 — upside +10%
Today : $9.91 — upside +152%
Expected +10% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-33.3%
stock -33% · XLV -2%
UBS
Oct 8, 24
▲ Buy · 🎯$29
Price at call : $24.77 — upside +17%
Today : $9.91 — upside +193%
Expected +17% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 0% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
-45.3%
stock -45% · XLV -6%
Barclays
Jul 29, 24
▲ Overweight · 🎯$28
Price at call : $27.65 — upside +1%
Today : $9.91 — upside +183%
Expected +1% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-50.1%
stock -50% · XLV -11%
Baird
Jul 29, 24
▲ Outperform · 🎯$27
Price at call : $26.25 — upside +3%
Today : $9.91 — upside +172%
Expected +3% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
-46.6%
stock -47% · XLV -10%
▲ Outperform · 🎯$27
Price at call : $21.01 — upside +29%
Today : $9.91 — upside +172%
Expected +29% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 33% (9 calls matureds) · 📊 on Health : 35.3% · -9.2% (34 calls)
-33.9%
stock -34% · XLV -5%
Barclays
Jun 28, 24
▲ Overweight · 🎯$25
Price at call : $20.77 — upside +20%
Today : $9.91 — upside +152%
Expected +20% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-35.2%
stock -35% · XLV -7%
Baird
Apr 29, 24
▲ Outperform · 🎯$26
Price at call : $24.08 — upside +8%
Today : $9.91 — upside +162%
Expected +8% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
-47.3%
stock -47% · XLV -1%
Barclays
Apr 10, 24
▲ Overweight · 🎯$30
Price at call : $25.55 — upside +17%
Today : $9.91 — upside +203%
Expected +17% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-40.4%
stock -40% · XLV -3%
▲ Outperform · 🎯$28
Price at call : $25.87 — upside +8%
Today : $9.91 — upside +183%
Expected +8% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 33% (9 calls matureds) · 📊 on Health : 35.3% · -9.2% (34 calls)
-41.1%
stock -41% · XLV -6%
Baird
Feb 15, 24
▲ Outperform · 🎯$26
Price at call : $23.76 — upside +9%
Today : $9.91 — upside +162%
Expected +9% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
-27.0%
stock -27% · XLV -1%
Barclays
Feb 15, 24
▲ Overweight · 🎯$27
Price at call : $24.05 — upside +12%
Today : $9.91 — upside +172%
Expected +12% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-25.7%
stock -26% · XLV -0%
Raymond James
Jan 26, 24
▲ Outperform · 🎯$26
Price at call : $22.66 — upside +15%
Today : $9.91 — upside +162%
Expected +15% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 42% (12 calls matureds) · 📊 on Health : 42.2% · -4.2% (109 calls)
-0.8%
stock -1% · XLV +6%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)